US BANCORP \DE\ - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$4,000
+300.0%
54
+22.7%
0.00%
Q2 2022$1,000
-92.9%
44
-89.1%
0.00%
Q1 2022$14,000
-62.2%
403
-67.6%
0.00%
Q4 2021$37,000
+2.8%
1,243
-10.3%
0.00%
Q3 2021$36,000
+12.5%
1,385
+52.7%
0.00%
Q2 2021$32,000
+220.0%
907
+258.5%
0.00%
Q1 2021$10,000
-44.4%
253
-37.7%
0.00%
Q4 2020$18,000
-77.8%
406
-72.5%
0.00%
Q3 2020$81,000
-11.0%
1,474
+2.5%
0.00%
Q2 2020$91,000
+139.5%
1,438
+93.0%
0.00%
Q1 2020$38,000
-36.7%
745
-1.5%
0.00%
Q4 2019$60,000
+5900.0%
756
+6772.7%
0.00%
Q3 2019$1,000
-90.9%
11
-94.7%
0.00%
Q1 2019$11,000
-42.1%
209
-55.2%
0.00%
Q4 2018$19,000
-50.0%
466
-53.2%
0.00%
Q3 2018$38,000
-15.6%
9950.0%0.00%
Q2 2018$45,000
+650.0%
995
+514.2%
0.00%
Q4 2017$6,0001620.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders